Literature DB >> 3314725

Perioperative dissemination of Salmonella.

M Uhari1, H Rantala, E Herva.   

Abstract

A hypophyseal adenoma was operated on in a patient who was a carrier of Salmonella typhimurium. A chronic salmonella osteitis developed in her calvarium at the site of operation. Our case and reported experience emphasise that asymptomatic carriers of salmonella should be given perioperative antibiotic prophylaxis, especially if they are immunosuppressed.

Entities:  

Mesh：

Year:  1987        PMID： 3314725      PMCID： PMC1778694          DOI： 10.1136/adc.62.10.1079

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  Salmonellosis in patients with neoplastic disease. A review of 100 episodes at Memorial Cancer Center over a 13-year period.

Authors:  M S Wolfe; D B Louria; D Armstrong; A Blevins
Journal:  Arch Intern Med       Date:  1971-10

2.  Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center.

Authors:  I SAPHRA; J W WINTER
Journal:  N Engl J Med       Date:  1957-06-13       Impact factor: 91.245

3.  Treatment of Salmonella gastroenteritis in infants. The significance of bacteremia.

Authors:  H S Raucher; A H Eichenfield; H L Hodes
Journal:  Clin Pediatr (Phila)       Date:  1983-09       Impact factor: 1.168

Review 4.  Salmonella focal intracranial infections: review of the world literature (1884-1984) and report of an unusual case.

Authors:  R E Rodriguez; V Valero; C Watanakunakorn
Journal:  Rev Infect Dis       Date:  1986 Jan-Feb

5.  Bone and joint infections due to Salmonella.

Authors:  C Ortiz-Neu; J S Marr; C E Cherubin; H C Neu
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

6.  Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever.

Authors:  R H Gilman; M Terminel; M M Levine; P Hernandez-Mendoza; R B Hornick
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.